Ultragenyx Pharmaceutical Inc. - COM (RARE)

Q2 2022 13F Holders as of 6/30/2022

Type / Class
Equity / COM
Number of holders
209
Total Shares
67.5M
Shares change
+620K
Total reported value, excl. options
$4.03B
Value change
+$25.5M
Put/Call ratio
1.13
Number of buys
110
Number of sells
-109
Price
$59.66
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.